Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9061071
Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels
granted -
US 9061981
Diphenyl substituted cyclohexane derivatives, useful as modulators of the estrogen receptors beta
granted -
US 9061055
Oncolytic adenovirus armed with therapeutic genes
granted -
US 9061030
sGC stimulators
granted -
US 9061048
Cyclic di-AMP induction of type I interferon
granted -
US 9063153
Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
granted -
US 9061027
Enhanced delivery of drug compositions to treat life threatening infections
granted -
EP 2882753
VERFAHREN ZUR HERSTELLUNG VON PEMETREXED UND EINEM LYSINSALZ DAVON
granted -
US 9056873
Substituted 6-aza-isoindolin-1-one derivatives
granted -
US 9057054
Antigen-specific long-term memory T-cells
granted -
US 9056068
Vaccine and methods of use against Strongyloide stercoralis infection
granted -
US 9056129
Precision-guided nanoparticle systems for drug delivery
granted -
US 9056102
VEGF-activated trail ligands
granted -
US 9056847
Activity based probes (ABPs) interacting with glycosidases
granted -
US 9056130
Humanized Fc gamma R mice
granted -
US 9056046
Standardized extract and its use in the manufacture of a medicament
granted -
US 9056087
Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives
granted -
US 9056891
Synthetic peptide inhibitors of Wnt pathway
granted -
US 9057104
Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype
granted -
US 9056100
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 9056127
Hydrogel composition based on co-polymer carrying multiple pendant sulphonic groups for use as a wound dressing
granted -
US 9057069
Compositions and methods for inhibiting expression of Eg5 gene
granted -
US 9056924
Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
granted -
US 9056054
Abuse resistant oral dosage forms
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.